Patents by Inventor Valerie Denise Harding

Valerie Denise Harding has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6699847
    Abstract: Long-acting antiparasitic formulations of doramectin, suitable for injection, are described herein.
    Type: Grant
    Filed: November 7, 2001
    Date of Patent: March 2, 2004
    Assignee: Pfizer Inc.
    Inventors: Stephen Richard Wicks, Timothy Michael Lukas, Valerie Denise Harding, Snezana Milojevic
  • Patent number: 6632803
    Abstract: The invention provides pharmaceutical formulation comprising voriconazole, or a pharmaceutically acceptable derivative thereof, and a sulfobutylether &bgr;-cyclodextrin.
    Type: Grant
    Filed: September 29, 1999
    Date of Patent: October 14, 2003
    Assignee: Pfizer Inc
    Inventor: Valerie Denise Harding
  • Publication number: 20020142972
    Abstract: Long-acting antiparasitic formulations of doramectin, suitable for injection, are described herein.
    Type: Application
    Filed: November 7, 2001
    Publication date: October 3, 2002
    Applicant: Pfizer Inc.
    Inventors: Stephen Richard Wicks, Timothy Michael Lukas, Valerie Denise Harding, Snezana Milojevic
  • Patent number: 6380226
    Abstract: A crystalline, &bgr;-polymorphic form of a compound of formula (I):
    Type: Grant
    Filed: June 15, 2000
    Date of Patent: April 30, 2002
    Assignee: Pfizer Inc
    Inventors: Valerie Denise Harding, Ross James Macrae, Ronald James Ogilvie
  • Patent number: 6166025
    Abstract: The present invention provides an aqueous pharmaceutical composition comprising 5 to 200 mg/ml of eletriptan hemisulfate and from 0.5 to 2.0% weight/volume of caffeine.
    Type: Grant
    Filed: January 27, 2000
    Date of Patent: December 26, 2000
    Assignee: Pfizer Inc.
    Inventors: Valerie Denise Harding, Anne Billotte
  • Patent number: 6110940
    Abstract: The present invention relates to hydrobromide salts of 3-(N-methyl-2(R)-pyrrolidinylmethyl)-5-(2-phenylsulphonylethyl)-1H-indole having the formula (I): ##STR1##
    Type: Grant
    Filed: February 2, 1997
    Date of Patent: August 29, 2000
    Assignee: Pfizer Inc.
    Inventors: Valerie Denise Harding, Ross James Macrae, Ronald James Ogilvie